Testing effectiveness (Phase 2)Looking for participantsNCT07011654
What this trial is testing
Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
Who this might be right for
Metastatic Triple-Negative Breast Cancer
M.D. Anderson Cancer Center 31